Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer.


Journal

Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 26 06 2020
accepted: 09 11 2020
pubmed: 14 11 2020
medline: 24 6 2021
entrez: 13 11 2020
Statut: ppublish

Résumé

To evaluate the relationship of circulating immune cells with recurrence and metabolic/lifestyle factors in patients with early-stage breast cancer. Patients with early-stage breast cancer were identified from the electronic record and institutional registry. Lymphocyte and monocyte counts were obtained from blood samples at time of diagnosis prior to any chemotherapy. Correlations between lymphocyte and monocyte and recurrence were assessed in the entire cohort and among obese patients, those reporting alcohol consumption and smoking. Competing risk regression was used to analyze time to recurrence. A total of 950 patients with ≥ 5 years of follow-up were identified; 433 had complete data and were eligible for analysis. 293 (68%) had hormone receptor-positive breast cancer, 82 (19%) HER2 positive, and 53 (13%) triple negative. Patients in the highest quintile of lymphocytes compared to the lowest quintile had lower risk of recurrence (subhazard ratio (SHR) = 0.17, 95% CI [0.03-0.93], p = 0.041) while patients in the highest quintile of monocytes had lower risk for recurrence (SHR = 0.19, 95% CI [0.04, 0.92], p = 0.039). Higher monocytes were more strongly associated with lower recurrence among those reporting alcohol consumption (HR = 0.10, 95% CI [0.01, 0.91], p = 0.04). In obese patients, higher lymphocytes were associated with lower risk of recurrence (p = 0.046); in non-obese patients, higher monocytes were associated with lower risk of recurrence (p = 0.02). There were no correlations among patients who reported tobacco use. High lymphocyte and monocyte counts are associated with lower recurrence rate in early-stage breast cancer, particularly in obese patients and those reporting alcohol consumption.

Identifiants

pubmed: 33185832
doi: 10.1007/s10549-020-06016-3
pii: 10.1007/s10549-020-06016-3
pmc: PMC9271265
mid: NIHMS1646714
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

561-568

Subventions

Organisme : NCI NIH HHS
ID : K08 CA237863
Pays : United States

Références

Oncotarget. 2017 Dec 14;8(69):114268-114280
pubmed: 29371985
J Biol Chem. 2016 Jan 1;291(1):149-59
pubmed: 26527689
Medicine (Baltimore). 2015 Dec;94(49):e2266
pubmed: 26656374
Medicine (Baltimore). 2018 May;97(21):e10759
pubmed: 29794753
Oncology (Williston Park). 2018 Aug 15;32(8):410-7
pubmed: 30153321
Clin Cancer Res. 2018 Jun 15;24(12):2851-2858
pubmed: 29581131
Am J Epidemiol. 1993 Jan 1;137(1):49-53
pubmed: 8434572
Sci Rep. 2016 Sep 27;6:34310
pubmed: 27670158
Cancer Manag Res. 2019 Apr 18;11:3371-3379
pubmed: 31114373
Dis Esophagus. 2016 Oct;29(7):740-746
pubmed: 26316375
JAMA Oncol. 2016 Oct 01;2(10):1354-1360
pubmed: 27355489
Diabetologia. 2013 Aug;56(8):1856-66
pubmed: 23616239
Immunol Lett. 2016 Aug;176:81-9
pubmed: 27269375
J Clin Oncol. 2010 Jun 1;28(16):2784-95
pubmed: 20404251
Breast Cancer Res. 2015 Aug 05;17:101
pubmed: 26243145
BMC Cancer. 2018 Oct 16;18(1):982
pubmed: 30326862
Front Immunol. 2017 Jun 09;8:643
pubmed: 28649243
Eur J Cancer. 2006 Apr;42(6):717-27
pubmed: 16520032
Cell Mol Life Sci. 2015 Nov;72(21):4111-26
pubmed: 26210152
J Clin Oncol. 2010 Oct 10;28(29):4410-6
pubmed: 20805458
J Clin Oncol. 2013 Nov 1;31(31):3997-4013
pubmed: 24101045
BMC Gastroenterol. 2018 Oct 11;18(1):148
pubmed: 30305076
Front Immunol. 2018 Nov 05;9:2556
pubmed: 30455701

Auteurs

Eric Xie (E)

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 201 North Broadway, Rm 10262, Baltimore, MD, 21287, USA.

Maya M Lapinski (MM)

Johns Hopkins University Department of Biomedical Engineering, Baltimore, MD, USA.

Sarah Talamantes (S)

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.

Bareng A S Nonyane (BAS)

Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Maria Cristina Figueroa Magalhães (MCF)

Pontifícia Universidade Católica Do Paraná, Curitiba, Brazil.

Kala Visvanathan (K)

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 201 North Broadway, Rm 10262, Baltimore, MD, 21287, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Antonio C Wolff (AC)

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 201 North Broadway, Rm 10262, Baltimore, MD, 21287, USA.

Cesar A Santa-Maria (CA)

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, 201 North Broadway, Rm 10262, Baltimore, MD, 21287, USA. csantam2@jhmi.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH